ClinicalTrials.Veeva

Menu

Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy (TRANSCOVID)

C

Centre Hospitalier Universitaire de Besancon

Status

Completed

Conditions

Sars-CoV2

Treatments

Diagnostic Test: biological samples day of delivery

Study type

Interventional

Funder types

Other

Identifiers

NCT04402918
2020/500

Details and patient eligibility

About

The study evaluates the distribution of immunological and virological profiles of newborns patients. Mothers of these children have a proven infection to SARS Cov-2 during pregnancy.

Enrollment

160 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant woman
  • diagnosed with Sars Cov-2 during pregnancy
  • singleton or twin pregnancy
  • informed consent

Exclusion criteria

  • virological or serological samples not done the day of delivery

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

160 participants in 1 patient group

pregnancy patients diagnosed with SARS Cov2 during pregnancy
Other group
Description:
Delivery day biological samples from the mother and the newborn will be performed
Treatment:
Diagnostic Test: biological samples day of delivery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems